(CNN) - Jason Gallagher, an infectious disease pharmacist in Philadelphia had gotten the Johnson & Johnson Covid-19 vaccine through a clinical trial in November, but this summer he didn't like the direction Covid-19 cases were taking due to variants.
"Come June, I started to get nervous about this Delta variant spreading and had some travel plans," said Gallagher, a clinical professor at Temple University School of Pharmacy.
More than 13.2 million people in the US have gotten the J&J single dose vaccine, according to the CDC. The vaccine is effective and protects well against hospitalization and death, studies show.
#Johnson&Johnson
#Covid19
#CDC
Follow Me:
Instagram → https:// www.instagram.com/invites/contact/?i=w66vnc9smq73&utm_content=m7ozpxf
Twitter → https://twitter.com/SENChansophear1
Facebook → https://www.facebook.com/N24Com-111058277923642/?ref=page_internal
Telegram → https://t.me/SENCHANSOPHEARK
0 Comments